As most of you probably know, biotechnology company Serono, based in Geneva, Switzerland, agreed in October to pay $704 million to the United States federal government to settle charges that it illegally marketed its AIDS drug Serostim. According to newspaper reports, the settlement was the third-largest ever recovered by the government in a healthcare fraud case. As part of the settlement, Serono Holding Co. entered into what is called a corporate integrity agreement with the Office of ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to The Serono Effect, you'll get exclusive access to a large archive of premium content.

Already registered? here.